K. Ahmed

发表

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Jacob G. Scott, Eric Mellon, Eduardo Moros, 2017, The Lancet. Oncology.

Host and graft thickness after Descemet stripping endothelial keratoplasty for Fuchs endothelial dystrophy.

Sanjay V. Patel, J. McLaren, Keith H Baratz, 2010, American journal of ophthalmology.

Vibrio harveyi flavin reductase--luciferase fusion protein mimics a single-component bifunctional monooxygenase.

S. Tu, K. Ahmed, Navneet Jawanda, 2008, Biochemistry.

Altered fractionation schedules in radiation treatment: a review.

T. Dilling, R. Shridhar, C. Correa, 2014, Seminars in oncology.

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy.

S. Eschrich, R. Wenham, J. Torres-Roca, 2019, International journal of radiation oncology, biology, physics.

Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.

S. Eschrich, J. Torres-Roca, B. Yue, 2016, International journal of radiation oncology, biology, physics.

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.

S. Eschrich, J. Torres-Roca, T. Dilling, 2014, International journal of radiation oncology, biology, physics.

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

B. Czerniecki, M. Vogelbaum, Hyo S Han, 2021, BMC cancer.

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

B. Czerniecki, M. Vogelbaum, Hyo S Han, 2021, BMC Cancer.

Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease

B. Czerniecki, Hyo S Han, A. Soyano, 2022, Journal of Neuro-Oncology.

Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases

B. Czerniecki, M. Vogelbaum, Hyo S Han, 2021, Journal of Neuro-Oncology.

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study

B. Czerniecki, N. Tran, Hyo S Han, 2021, Advances in radiation oncology.

Management of brain metastases in breast cancer: a review of current practices and emerging treatments

B. Czerniecki, M. Vogelbaum, Hyo S Han, 2020, Breast Cancer Research and Treatment.

Breast leptomeningeal disease: a review of current practices and updates on management

B. Czerniecki, Hyo S Han, J. Arrington, 2019, Breast Cancer Research and Treatment.

Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: a population-based analysis.

R. Wilder, K. Ahmed, 2014, Cancer epidemiology.

Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource Settings.

A. Naghavi, D. Fernandez, M. Echevarria, 2016, International journal of radiation oncology, biology, physics.

Modeling precision genomic-based radiation dose response in rectal cancer.

J. Torres-Roca, M. Schell, S. Hoffe, 2020, Future oncology.

Postoperative Stereotactic Radiosurgery Using 5-Gy × 5 Sessions in the Management of Brain Metastases.

P. Johnstone, A. Naghavi, P. Venkat, 2016, World neurosurgery.

Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases

K. Ahmed, P. Chinnaiyan, N. Figura, 2014, Journal of Neuro-Oncology.

Progress in Gene Therapy for Prostate Cancer

B. Davis, G. Wiseman, M. Federspiel, 2012, Front. Oncol..

The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.

B. Fridley, L. Loftus, P. Blumencranz, 2019, Journal of geriatric oncology.

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

P. Brastianos, M. Atkins, H. Tawbi, 2020, Pigment cell & melanoma research.

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

V. Sondak, M. Herlyn, M. Atkins, 2019, Pigment cell & melanoma research.

Stereotactic radiosurgery for patients with recurrent intracranial ependymomas

M. Link, K. Ahmed, P. Schomberg, 2012, Journal of Neuro-Oncology.

Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization

Jacob G. Scott, John E. Mullinax, J. Torres-Roca, 2021, Translational oncology.

The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.

S. Eschrich, J. Torres-Roca, P. Johnstone, 2017, Neuro-oncology.

Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma

Jacob G. Scott, John E. Mullinax, T. Strom, 2017, Journal of contemporary brachytherapy.

Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma

L. Harrison, T. Robinson, A. Naghavi, 2017, Therapeutic advances in hematology.

Stereotactic body radiation therapy in spinal metastases.

P. Brown, RobertI Miller, K. Olivier, 2012, International journal of radiation oncology, biology, physics.

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases

T. Dilling, L. Harrison, P. Johnstone, 2017, Journal of Neuro-Oncology.

The Lung Graded Prognostic Assessment: Continued Evolution of Brain Metastases Prognostication.

K. Ahmed, D. Oliver, H. Yu, 2022, International journal of radiation oncology, biology, physics.

High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.

R. Wenham, D. Hunt, H. Chon, 2019, Gynecologic oncology.

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

N. Tran, T. Robinson, P. Forsyth, 2018, Breast Cancer Research and Treatment.

Clinical Outcome in the Use of Cephalosporins in Pediatric Patients with a History of Penicillin Allergy

Miguel Park, K. Ahmed, E. Frigas, 2012, International Archives of Allergy and Immunology.

The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs

B. Czerniecki, M. Vogelbaum, J. Arrington, 2021, Breast Cancer Research and Treatment.

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy

C. Mayo, K. Olivier, D. Owen, 2015, Advances in radiation oncology.

Clinical Benefits of Proton Beam Therapy for Tumors of the Skull Base.

P. Johnstone, M. McDonald, K. Ahmed, 2016, Cancer control : journal of the Moffitt Cancer Center.

Case series of sixteen patients with nummular headache

K. Ahmed, I. Garza, Justin S Moon, 2010, Cephalalgia : an international journal of headache.

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy

S. Eschrich, R. Wenham, J. Torres-Roca, 2019, International Journal of Radiation Oncology*Biology*Physics.

Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.

T. Strom, K. Latifi, K. Ahmed, 2015, Journal of neurosurgery.

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.

Jacob G. Scott, M. Kattan, S. Eschrich, 2021, The Lancet. Oncology.

Clinical Outcomes of Non-Small Cell Lung Cancer Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitors, EGFR Tyrosine Kinase Inhibitors, Chemotherapy and Immune Checkpoint Inhibitors, or Chemotherapy Alone.

T. Robinson, J. Gray, B. Creelan, 2021, International journal of radiation oncology, biology, physics.

Management of Oropharyngeal Cancer in the HPV Era.

T. Strom, L. Harrison, A. Naghavi, 2016, Cancer control : journal of the Moffitt Cancer Center.

Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy.

J. Torres-Roca, L. Harrison, A. Naghavi, 2019, Seminars in radiation oncology.

Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma

I. Nakano, Shiva Kant, P. Forsyth, 2018, Neuro-oncology.

The radiosensitivity index predicts for overall survival in glioblastoma

Steven Eschrich, William J Fulp, Prakash Chinnaiyan, 2015, Oncotarget.

Applying Metabolomics to Understand the Aggressive Phenotype and Identify Novel Therapeutic Targets in Glioblastoma

Prakash Chinnaiyan, K. Ahmed, P. Chinnaiyan, 2014, Metabolites.

Harnessing Tumor Immune Ecosystem Dynamics to Personalize Radiation Therapy

S. Eschrich, J. Torres-Roca, J. Cleveland, 2020 .

Harnessing tumor immune ecosystem dynamics to personalize radiotherapy

S. Eschrich, J. Torres-Roca, J. Cleveland, 2020, bioRxiv.

Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.

Jacob G. Scott, R. Gonzalez, M. Bui, 2016, Brachytherapy.

Breast and Soft Tissue Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma

Jacob G. Scott, R. Gonzalez, M. Bui, 2016 .

GARD is a pan-cancer predictor of radiation therapy benefit

Jacob G. Scott, M. Kattan, S. Eschrich, 2020 .

Alterations in genetic pathways following radiotherapy for head and neck cancer

A. Naghavi, J. Caudell, Youngchul Kim, 2019, Head & neck.

Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management.

Sungjune Kim, Louis B Harrison, L. Harrison, 2017, Surgical oncology clinics of North America.

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2019, EBioMedicine.

Laparoscopic vs open distal pancreatectomy: a single-institution comparative study.

J. Donohue, W. Harmsen, M. Farnell, 2010, Archives of surgery.

Miliary breast cancer brain metastasis: a rare and aggressive form of central nervous system metastasis

K. Ahmed, M. Mills, 2020, British Journal of Cancer.

Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis.

S. Hoover, C. Laronga, R. Costa, 2018, European journal of cancer.

Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2- Breast Cancer Treated With Preoperative Stereotactic Ablative Body Radiotherapy.

N. Raghunand, O. Stringfield, B. Czerniecki, 2022, Journal of breast imaging.

Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases

A. Keller, P. Johnstone, T. Robinson, 2020, American journal of clinical oncology.

The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer

A. Giuliano, P. Spiess, P. Johnstone, 2018, World Journal of Urology.

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

J. Torres-Roca, B. Czerniecki, H. Soliman, 2018, International journal of breast cancer.

Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions

W. Woodward, J. Torres-Roca, E. Harris, 2021, Advances in radiation oncology.

Radiation therapy in the management of the inguinal region in penile cancer: What's the evidence?

J. Torres-Roca, P. Spiess, P. Johnstone, 2020, Urologic oncology.

Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy.

A. Giuliano, J. Torres-Roca, P. Spiess, 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Pretreatment Neutrophil-Lymphocyte Ratio (NLR) Does Not Predict Worse Outcomes in Anal Cancer

T. Strom, R. Shridhar, S. Hoffe, 2014 .

Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases

K. Ahmed, P. Chinnaiyan, A. Etame, 2016, American journal of clinical oncology.

Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies

N. Tran, M. Vogelbaum, P. Forsyth, 2022, Frontiers in Oncology.

Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases

P. Johnstone, K. Ahmed, A. Etame, 2016, Melanoma research.

LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases

G. Gibney, J. Weber, P. Forsyth, 2015, Journal of Neuro-Oncology.

Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies

T. Strom, L. Harrison, A. Naghavi, 2016, Cancer.

Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy.

O. Stringfield, B. Czerniecki, M. Abdalah, 2023, International journal of radiation oncology, biology, physics.

Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations

L. Harrison, T. Robinson, J. Chavez, 2018, Leukemia & lymphoma.

CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases

N. Tran, T. Robinson, J. Arrington, 2019, Journal of Neuro-Oncology.

Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’

B. Davis, E. Bergstralh, L. Mynderse, 2014, Radiation Oncology.

Stereotactic Radiosurgery for Vertebral Metastases

K. Ahmed, D. Oliver, A. Rishi, 2021, Image Guided Interventions of the Spine.

Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy

B. Czerniecki, N. Tran, T. Robinson, 2019, Breast Cancer Research and Treatment.

Stage IIA and IIB testicular seminoma treated post-orchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients

R. Wilder, K. Ahmed, 2015, International braz j urol : official journal of the Brazilian Society of Urology.

Histologically Proven, Low-grade Brainstem Gliomas in Children: 30-Year Experience With Long-term Follow-up at Mayo Clinic

N. Wetjen, L. Eckel, Nicholas M. Orme, 2014, American journal of clinical oncology.

Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.

J. Torres-Roca, K. Ahmed, 2016, Cancer control : journal of the Moffitt Cancer Center.

Patient choice for high‐volume center radiation impacts head and neck cancer outcome

T. Strom, C. Chung, L. Harrison, 2018, Cancer medicine.

Triggered kV Imaging During Spine SBRT for Intrafraction Motion Management

E. Moros, K. Latifi, V. Feygelman, 2021, Technology in cancer research & treatment.

Neurodevelopmental Outcomes Following Intravitreal Bevacizumab With Laser Versus Laser Photocoagulation Alone for Retinopathy of Prematurity.

K. Ahmed, M. Greven, Anam S Ali, 2020, Ophthalmic surgery, lasers & imaging retina.

MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity.

N. Raghunand, O. Stringfield, B. Czerniecki, 2021, Clinical breast cancer.

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability

S. Eschrich, J. Torres-Roca, J. Cleveland, 2021, Neoplasia.

Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization

M. Malafa, A. Naghavi, S. Hoffe, 2016, World journal of gastroenterology.

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer

Sean S. Park, B. Davis, K. Olivier, 2013, Front. Oncol..

Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE)

D. Boulware, C. Laronga, K. Ahmed, 2018, Breast Cancer Research and Treatment.

Stereotactic Body Radiotherapy in the Treatment of Adrenal Metastases

Robert L. Foote, Nadia N. Laack, RobertI Miller, 2013, American journal of clinical oncology.

Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’

B. Davis, E. Bergstralh, L. Mynderse, 2014, Radiation oncology.

Comparison of Definitive Cervical Cancer Management With Chemotherapy and Radiation Between Two Centers With Variable Resources and Opportunities for Improved Treatment

R. Wenham, H. Chon, D. Fernandez, 2020, JCO global oncology.

The Radiosensitivity Index (RSI) Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated with Susceptibility to Radiotherapy.

S. Eschrich, J. Torres-Roca, J. Cleveland, 2022, International journal of radiation oncology, biology, physics.

Treatment delays, race, and outcomes in head and neck cancer.

T. Strom, L. Harrison, B. Green, 2016, Cancer epidemiology.

Race Is Associated With Poor Outcomes in Head and Neck Cancer

T. Strom, L. Harrison, B. Green, 2016 .

Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1-Negative Metastatic Squamous Cell Carcinoma of the Lung.

T. Dilling, S. Antonia, K. Ahmed, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes following SBRT.

S. Eschrich, J. Torres-Roca, A. Berglund, 2016 .

EP-2302: Differences in the Radiosensitivty Index (RSI) Between Metastatic and Primary Breast Cancer

J. Torres-Roca, K. Ahmed, R. Diaz, 2018 .

Evaluation of prevalence of different types of cancer and its chemotherapy in various ethnic groups of Pakistan: A retrospective study

M. Azeem, K. Ahmed, M. Akhtar, 2020, Brazilian Journal of Pharmaceutical Sciences.

Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy.

G. Gibney, L. Harrison, P. Johnstone, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Stereotactic Radiosurgery and Anti-PD-1 + CTLA-4 Therapy, Anti-PD-1 Therapy, Anti-CTLA-4 Therapy, BRAF/MEK Inhibitors, BRAF Inhibitors, or Conventional Chemotherapy for the Management of Melanoma Brain Metastases

N. Tran, M. Vogelbaum, Youngchul Kim, 2023, European Journal of Cancer.

Surgical and Anatomic Factors Predict Development of Leptomeningeal Disease in Patients with Melanoma Brain Metastases.

N. Tran, M. Vogelbaum, Junmin Whiting, 2022, Neuro-oncology.

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.

L. Harrison, P. Johnstone, A. Naghavi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Response of Osteosarcoma to Chemotherapy. Evaluation with F-18 FDG-PET Scans.

Hollinger, A. Green, K. Ahmed, 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.

P. Brastianos, E. Hernando-Monge, K. Smalley, 2023, Pigment cell & melanoma research.

Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.

G. Hanna, K. Ahmed, B. Kayani, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases

M. Vogelbaum, P. Forsyth, H. Soliman, 2023, Journal of Neuro-Oncology.

Neoadjuvant Simultaneous Integrated Boost Radiotherapy Improves Clinical Outcomes for Retroperitoneal Sarcoma: Neoadjuvant Simultaneous Integrated Boost Radiotherapy for Retroperitoneal Sarcoma.

P. Johnstone, A. Naghavi, K. Ahmed, 2023, International Journal of Radiation Oncology, Biology, Physics.

Characterization of Immune Infiltrates Associated With Radiation Necrosis in the Setting of Brain Metastases Following Stereotactic Radiosurgery and Immunotherapy: A Retrospective Cohort Analysis

K. Ahmed, A. Etame, R. Macaulay, 2023, Cureus.

Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management.

L. Harrison, K. Ahmed, Sungjune Kim, 2017, Surgical oncology clinics of North America.

Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.

T. Strom, K. Latifi, K. Ahmed, 2015, Journal of neurosurgery.

Laparoscopic vs open distal pancreatectomy: a single-institution comparative study.

J. Donohue, W. Harmsen, M. Farnell, 2010, Archives of surgery.